Ivermectin Surge: Mel Gibson’s Podcast Bombshell!

Two scientists conducting an experiment in a laboratory, one looking through a microscope and the other holding a flask with blue liquid

A quiet revolt against the medical establishment is driving desperate cancer patients toward ivermectin, and the data now show Joe Rogan’s podcast poured gasoline on that fire.

Story Snapshot

Prescriptions for ivermectin and related antiparasitic drugs surged among cancer patients after Mel Gibson’s 2025 appearance on Joe Rogan’s show.
Laboratory studies suggest ivermectin can kill or slow cancer cells, but doctors say there is still no proven benefit in humans.
Federal cancer researchers are now formally testing ivermectin in combination with standard treatments, while warning against replacing proven therapies.
The clash reflects a deeper breakdown of trust as patients turn to podcasts and social media after years of establishment mismanagement and censorship.

Celebrity Podcast, Desperate Patients, and a Prescription Spike

Researchers at a major university hospital reviewed prescribing records before and after actor Mel Gibson appeared on Joe Rogan’s podcast in January 2025, where he described three friends with stage four cancer who he said recovered after taking ivermectin and fenbendazole. They found prescriptions for the ivermectin–benzimidazole combination more than doubled overall, and more than two and a half times higher among cancer patients in the following months, with the sharpest increase in the American South.

Separate reporting on oncology practices confirms that interest in ivermectin and fenbendazole has “spread like wildfire,” with even patients already on chemotherapy or immunotherapy asking to add these drugs as supplements. Cancer centers now see a steady stream of patients bringing podcast clips, online testimonies, and dosing protocols printed from alternative-health websites. This grassroots pressure is not coming from academic journals, but from families who feel they have been misled before and are determined to leave no stone unturned.

What the Science Actually Shows About Ivermectin and Cancer

Preclinical research paints a complicated picture. A 2024 scientific review concludes that ivermectin can inhibit cancer cell proliferation, trigger programmed cell death, and disrupt key signaling pathways such as Wnt/β-catenin and Akt/mTOR in laboratory and animal models across multiple tumor types.^[1] Detailed mechanistic work shows ivermectin blocking cancer-cell growth, metastasis, and blood-vessel formation; enhancing chemotherapy in ovarian cancer; and reducing melanoma spread in mice.^[3] These results explain why many doctors agree the drug is scientifically interesting.

However, the same review stresses that clinical evidence in human beings is “limited,” and that no large randomized controlled trials have yet confirmed a survival benefit or tumor shrinkage from ivermectin alone.^[1] Pediatric oncologists emphasize that the encouraging data come from cells in dishes and animals, not people, and warn families against assuming that lab success automatically translates into safe, effective treatment for children or adults.^[5] Cancer organizations similarly note that antiparasitic drugs like ivermectin and fenbendazole remain unproven as cancer therapies, especially as stand‑alone alternatives to chemotherapy, radiation, or immunotherapy.

Trials Underway: From Fringe to Formal Testing

Despite establishment skepticism, federal researchers have moved ivermectin out of the rumor mill and into formal study. The United States National Cancer Institute has launched early‑phase trials combining ivermectin with modern immunotherapy drugs such as pembrolizumab and balstilimab, seeking to determine safe dosing and whether the antiparasitic can boost immune attack on tumors.^[4] Another phase one and two study is examining safety and preliminary efficacy of ivermectin in patients who have already cycled through other cutting‑edge treatments.

Coverage of these efforts is blunt: there is still no evidence that ivermectin treats cancer effectively in humans, but the government’s leading cancer agency is explicitly studying its “ability to kill cancer cells” and enhance existing therapies.^[6] That combination—strong lab science, intense public interest, and official acknowledgment that questions remain—has left many conservative patients skeptical of blanket media statements claiming the drug is “debunked.” People remember how discussion of off‑label ivermectin during the virus era was mocked and censored, only to see federal scientists quietly circle back when headlines moved on.

Risk, Responsibility, and the Trust Gap in Modern Medicine

Oncologists warn that the greatest danger is not carefully supervised experimental use, but patients who abandon or delay proven treatments while chasing online protocols. Professional groups highlight cases where individuals substituted animal‑grade fenbendazole or human ivermectin for standard therapy, risking toxicity, drug interactions, or uncontrolled disease progression. Cancer specialists also worry that enthusiasm driven by celebrity anecdotes can crowd out nuanced conversations about trial enrollment, real side effects, and realistic expectations.

Prescriptions for ivermectin and benzimidazole among cancer patients rose 2.5X after actor Mel Gibson endorsed the unproven treatment on Joe Rogan’s podcast, per a JAMA Network Open study. https://t.co/iQcosKJXt7

— Global Health NOW (@ghn_news) May 14, 2026

For many conservatives, the surge of interest in ivermectin is less about worshiping a “miracle cure” and more about refusing to surrender control to institutions that squandered trust through politicized science, censorship, and one‑size‑fits‑all mandates. The Trump administration’s second term faces a delicate balance: defending free speech and medical choice while insisting that desperate families get straight, transparent answers about what is known, what is unknown, and which options are backed by real human data. Cancer patients deserve both liberty and honesty, not nanny‑state suppression or false hope.